![](/wp-content/uploads/2018/10/ozX3eniJQBGkFR9Kugbu.png)
$599
J&J Q1 ’17 Earnings Update
J&J presented its Q1 ’17 earnings results and provided a brief update to its diabetes business including drugs and devices. Of note, J&J is hosting its Pharmaceutical Business Review on May 17.
J&J presented its Q1 ’17 earnings results and provided a brief update to its diabetes business including drugs and devices. Of note, J&J is hosting its Pharmaceutical Business Review on May 17.